Obesity Risks: Understanding Health Consequences & Prevention

Obesity (BMI ≥30) is a chronic, relapsing, multifactorial disease associated with >200 complications affecting nearly every organ system.

Major Health Consequences

Cardiometabolic:
• Hypertension, dyslipidemia, atherosclerosis → CAD, stroke, HFpEF.
• Type 2 Diabetes (T2D): Insulin resistance, β-cell dysfunction; 80–85% of T2D attributable to obesity.
• Metabolic Syndrome cluster.

Cancer (13 types linked by IARC): Endometrial, esophageal adenocarcinoma, gastric cardia, liver, kidney, multiple myeloma, meningioma, pancreatic, colorectal, gallbladder, breast (postmenopausal), ovarian, thyroid. Mechanisms: chronic inflammation, hyperinsulinemia, IGF-1, adipokines (leptin), estrogen from adipose.

Mechanical/Structural: Osteoarthritis (knee, hip, spine), chronic low back pain, GERD, obstructive sleep apnea (OSA), abdominal wall hernias, idiopathic intracranial hypertension.

Hepatic: NAFLD → NASH → fibrosis → cirrhosis → HCC (fastest rising indication for transplant).

Reproductive: PCOS, anovulation, infertility (female); hypogonadism, erectile dysfunction, reduced sperm quality (male). Pregnancy complications: GDM, preeclampsia, macrosomia, stillbirth.

Psychiatric: Depression, anxiety, binge eating disorder, weight stigma/bias → reduced healthcare access.

Immune/Inflammatory: Adipose tissue as endocrine organ secreting pro-inflammatory cytokines (TNF-α, IL-6, CRP) → chronic low-grade inflammation → impaired vaccine response, poor wound healing, severe COVID-19 outcomes.

Mortality: J-shaped curve; BMI 30–35: ~1–2 yr life lost; BMI >40: ~8–10 yr lost. CVD, cancer, diabetes leading causes.

Prevention & Management

• Lifestyle: 5–10% weight loss yields significant metabolic benefit. Mediterranean/DASH diet, 150+ min/week moderate activity, behavioral therapy.
• Pharmacotherapy: GLP-1 RAs (semaglutide, liraglutide), GIP/GLP-1 (tirzepatide), orlistat, phentermine-topiramate, naltrexone-bupropion.
• Bariatric Surgery: Sleeve gastrectomy, RYGB – most effective for severe obesity (BMI ≥40 or ≥35 with comorbidity); durable remission of T2D, hypertension, OSA.
• Multidisciplinary Care: Physician, dietitian, psychologist, exercise specialist.